Recombinant Collagen Sponge Material, Shaanxi Huikang, 2026
Summary
The European Patent Office published application EP3885359A1 for recombinant collagen and recombinant collagen sponge material, filed by Shaanxi Huikang Bio-Tech Co., Ltd. The patent covers biotechnological methods and compositions with inventors HE, Yue, WANG, Jiuna, and ZHAO, Jinli. Designated states cover 32 European Patent Convention member states including Germany, France, the United Kingdom, Italy, and Spain. Entities in the biotechnology and medical device sectors should monitor this IP development for competitive intelligence and potential licensing considerations.
About this source
GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 53 changes logged to date.
What changed
The EPO published European patent application EP3885359A1 for recombinant collagen and recombinant collagen sponge material filed by Shaanxi Huikang Bio-Tech Co., Ltd, with inventors HE, Yue, WANG, Jiuna, and ZHAO, Jinli. The application covers C07K 14/78, C12N 1/19, A61L 15/42, and related IPC classifications in biotechnology and pharmaceutical applications. Designated states cover 32 European Patent Convention member states. Competitors in the collagen-based biomaterials space and parties seeking to develop similar recombinant collagen products should conduct freedom-to-operate analyses and consider potential licensing discussions with the applicant.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RECOMBINANT COLLAGEN AND RECOMBINANT COLLAGEN SPONGE MATERIAL
Publication EP3885359A1 Kind: A1 Apr 15, 2026
Applicants
Shaanxi Huikang Bio-Tech Co., Ltd
Inventors
HE, Yue, WANG, Jiuna, ZHAO, Jinli
IPC Classifications
C07K 14/78 20060101AFI20220819BHEP C12N 1/19 20060101ALI20220819BHEP C08J 9/36 20060101ALI20220819BHEP A61L 15/42 20060101ALI20220819BHEP A61L 15/32 20060101ALI20220819BHEP C08L 89/00 20060101ALI20220819BHEP C12R 1/84 20060101ALI20220819BHEP C12N 15/12 20060101ALI20220819BHEP C12N 15/81 20060101ALI20220819BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.